JHSY(SZ:002597)2022-03-21 16:00Financial Performance - The company reported a total revenue of 556,166,953, with a cash dividend of 6.50 yuan per 10 shares (including tax) for all shareholders[8]. - The company's operating revenue for 2021 was ¥5,845,322,601.18, representing a 59.44% increase compared to ¥3,666,246,520.47 in 2020[28]. - The net profit attributable to shareholders for 2021 was ¥1,177,102,453.70, a 63.82% increase from ¥718,525,167.63 in 2020[28]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥994,751,755.94, up 74.51% from ¥570,031,064.08 in 2020[28]. - The company's total assets at the end of 2021 were ¥8,847,824,127.36, an increase of 26.43% from ¥6,998,152,136.98 at the end of 2020[28]. - The basic earnings per share for 2021 were ¥2.10, a 62.79% increase compared to ¥1.29 in 2020[28]. - The weighted average return on equity for 2021 was 22.09%, up from 15.50% in 2020[28]. - The net cash flow from operating activities for 2021 was ¥884,916,187.25, a decrease of 10.97% from ¥994,007,247.99 in 2020[28]. - The company reported a significant increase in government subsidies, amounting to ¥40,663,568.00 in 2021 compared to ¥32,645,283.08 in 2020[34]. - The total operating revenue for the reporting period reached ¥5,845,322,601.18, representing a year-on-year increase of 59.44%[91]. - Revenue from the food manufacturing segment was ¥3,029,083,784.52, accounting for 51.82% of total revenue, with a year-on-year growth of 59.32%[91]. - The basic chemical segment generated ¥2,350,644,250.65 in revenue, making up 40.21% of total revenue, with a year-on-year increase of 53.70%[91]. Business Operations - The company has no changes in its main business since its listing, indicating stability in operations[26]. - The company has a total of 5 wholly-owned subsidiaries and 1 holding subsidiary, enhancing its operational capabilities[17]. - The company has not undergone any changes in its controlling shareholder, indicating stability in ownership[26]. - The company has maintained its registered address and contact information, ensuring consistency in communication[21][22]. - The company has engaged Rongcheng Accounting Firm for auditing, ensuring compliance with financial regulations[27]. - The company has a total of 2,597 stock code listed on the Shenzhen Stock Exchange, reflecting its market presence[21]. - The company operates two major chemical parks, producing basic chemicals and food additives in Chuzhou[65]. - The company has a food production license valid until April 13, 2026, covering various food additives and sweeteners[68]. - The company has a high-tech enterprise certificate valid until September 18, 2024, indicating its commitment to innovation[68]. Market Position and Strategy - The company is positioned in the food manufacturing industry, benefiting from the growing demand for low-sugar and no-sugar products driven by health trends and government policies[42]. - The chemical industry, where the company operates, is experiencing increased demand and rising prices due to new safety and environmental regulations, as well as the impact of the COVID-19 pandemic on supply chains[43]. - The company has established a strategic layout and product line targeting the food and beverage, pharmaceutical health, and other industries, supported by a well-developed circular economy and public engineering facilities[44]. - The company is focused on diversifying its product lines and enhancing its industrial capabilities in bulk chemicals and functional chemical products[72]. - The company is actively adjusting sales strategies for sweeteners like Acesulfame and Sucralose to mitigate rising costs due to increased raw material prices and shipping fees[84]. - The company is leveraging its location in Anhui Province, close to the Yangtze River Delta, to optimize logistics and resource access[75]. - The company is focusing on expanding its product line in the food additives and flavoring sectors, aiming for significant breakthroughs in technology and market presence[80]. - The company plans to enhance its R&D capabilities by focusing on key catalytic technologies and green synthesis technologies[148]. Research and Development - The company holds 12 patents related to the production technology of sucralose, 12 patents for aspartame, 15 patents for ethyl maltol, and 4 patents for hydrogen peroxide, all indicating a strong R&D capability[64]. - The company has established a technology center and a post-doctoral workstation, enhancing its technological innovation and talent development[72]. - The company has established a comprehensive R&D platform to enhance product application solutions and improve production efficiency[77]. - The company completed several key R&D projects aimed at improving product competitiveness and operational efficiency[116]. - The number of R&D personnel increased by 5.74% to 516, with the proportion of R&D personnel in the company rising to 11.68%[116]. - Research and development expenses increased by 51.88% to ¥182,871,407.48, driven by an increase in R&D personnel and rising raw material costs[112]. Risk Management and Compliance - The company emphasizes the importance of risk awareness regarding forward-looking statements made in the report[7]. - The company has a risk management strategy in place to address environmental governance and safety production risks[153]. - The company maintains a robust governance structure, ensuring compliance with legal and regulatory requirements, and has not faced any administrative penalties[166]. - The board of directors consists of nine members, including three independent directors, ensuring compliance with governance standards[166]. - The company emphasizes transparent communication with investors, adhering to information disclosure regulations and maintaining open channels for investor feedback[167]. - The company operates independently from its controlling shareholders, ensuring that decision-making processes are not influenced by external parties[170]. Future Outlook - The company provided a positive outlook for the next quarter, projecting a revenue growth of 10% to 12%[188]. - New product launches are expected to contribute an additional 200 million RMB in revenue over the next fiscal year[188]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million RMB for potential targets[188]. - The management team emphasized the importance of sustainability initiatives, aiming to reduce operational costs by 8% through eco-friendly practices[188]. - The company aims to increase its flagship products or product clusters to five by the end of 2022 and successfully expand into one or two new business sectors[147]. Compensation and Governance - Total compensation for senior management during the reporting period amounted to 933.33 million CNY[197]. - The highest compensation was received by the Vice Chairman and General Manager, totaling 88.91 million CNY[197]. - The Chairman received a total compensation of 78.18 million CNY, while the Deputy General Manager received 78.97 million CNY[197]. - Independent directors received a total compensation of 8.33 million CNY each[197]. - The financial director's compensation was reported at 29.26 million CNY[197]. - The average age of the board members is approximately 52 years[197]. - The company has a total of 15 board members, including independent directors and supervisors[198]. - All board members attended all five board meetings held during the reporting period[198].